FGF23-related Hypophosphataemic Rickets and Osteomalacia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which FGF23-related Hypophosphataemic Rickets and Osteomalacia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06202027

Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients

The objective of this post-marketing surveillance (PMS) study is to assess the safety and effectiveness of CRYSVITA injection 10, 20, and 30mg, equivalent to in…

South Korea100 participantsStarted 2023-08-11

Treatment: FGF23-related hypophosphataemic rickets and osteomalacia

FGF23-related Hypophosphataemic Rickets and Osteomalacia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients

All recent trials (1 shown)